The Tamil Nadu Government has said that a pilot programme will start soon to study the efficacy of the Bacille Calmette-Guerin (BCG) vaccine in reducing morbidity and mortality due to coronavirus disease (Covid-19) in the elderly.
Following an order by Chief Minister Palaniswami, the BCG vaccine shall be administered on a trial basis, on adults aged 60-95, with the aim of reducing the Covid mortality rate within this set. The National Institute for Research in Tuberculosis (NIRT) will start the pilot programme soon, said C Vijayabaskar, Tamil Nadu Minister for Health and Family Welfare.
He added that NIRT will take up the